日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.

BVAC-C 治疗 HPV 16 型或 18 型阳性宫颈癌且一线铂类化疗失败患者的疗效和安全性：一项 I/IIa 期研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1371353
Choi Chel Hun, Lee Jeong-Won, Bae Duk-Soo, Kang Eun-Suk, Cho Duck, Kim Yong-Man, Kim Kidong, Kim Jae-Weon, Kim Hee Seung, Kim Young-Tae, Lee Jung-Yun, Lim Myong Cheol, Oh Taegwon, Song Boyeong, Jeon Insu, Park Myunghwan, Kim Wu Hyun, Kang Chang-Yuil, Kim Byoung-Gie
肿瘤
宫颈癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation for Cervical Cancer on Overall Survival

宫颈癌病理诊断至最终同步放化疗等待时间对总生存期的影响

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2021.023
Noh, Kyoung Won; Kim, Bomi; Choi, Chel Hun; Kim, Tae-Joong; Lee, Jeong-Won; Kim, Byoung-Gie; Bae, Duk-Soo; Cho, Won Kyung; Park, Won; Lee, Yoo-Young
宫颈癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Early Metabolic Response Assessed Using 18F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer

利用 18F-FDG-PET/CT 评估早期代谢反应，可更好地预测宫颈癌患者的腔内近距离放射治疗疗效。

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2020.1251
Kim, Nalee; Park, Won; Cho, Won Kyung; Bae, Duk-Soo; Kim, Byoung-Gie; Lee, Jeong-Won; Kim, Tae-Joong; Choi, Chel Hun; Lee, Yoo-Young; Cho, Young Seok
宫颈癌
肿瘤
肿瘤免疫
代谢
发表日期：2021
文献求助 收藏

Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features

血清CA125水平在具有不良特征的手术切除宫颈腺癌中的意义

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2021.32.e72
Kim, Nalee; Park, Won; Cho, Won Kyung; Bae, Duk Soo; Kim, Byoung Gie; Lee, Jeong Won; Choi, Chel Hun; Kim, Tae Joong; Lee, Yoo Young
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Minimally-Invasive Versus Abdominal Hysterectomy for Endometrial Carcinoma With Glandular or Stromal Invasion of Cervix

微创子宫切除术与开腹子宫切除术治疗伴有宫颈腺体或间质浸润的子宫内膜癌

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2021.670214
Jung, Jihee; Noh, Joseph J; Choi, Chel Hun; Kim, Tae-Joong; Lee, Jeong-Won; Kim, Byoung-Gie; Bae, Duk-Soo; Lee, Yoo-Young
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status

宫颈癌治疗前淋巴结转移的预后意义：疾病状态的比较

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2019.328
Jeong, Soo Young; Park, Hyea; Kim, Myeong Seon; Kang, Jun Hyeok; Paik, E Sun; Lee, Yoo-Young; Kim, Tae Joong; Lee, Jeong Won; Kim, Byoung-Gie; Bae, Duk Soo; Choi, Chel Hun
宫颈癌
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Feasibility of Single-Port Access (SPA) Laparoscopy for Large Ovarian Tumor Suspected to Be Borderline Ovarian Tumor

单孔腹腔镜手术治疗疑似交界性卵巢肿瘤的大型卵巢肿瘤的可行性

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2020.583515
Kang, Jun-Hyeok; Noh, Joseph J; Jeong, Soo Young; Shim, Jung In; Lee, Yoo-Young; Choi, Chel Hun; Lee, Jeong-Won; Kim, Byoung-Gie; Bae, Duk-Soo; Kim, Hyun-Soo; Kim, Tae-Joong
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer: Analysis by Radiation Phase and Histologic Type

局部晚期宫颈癌同步放化疗期间肿瘤消退率的预后意义：按放射治疗阶段和组织学类型分析

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm9113471
Kang, Jun-Hyeok; Cho, Won Kyung; Yeo, Hie Jun; Jeong, Soo Young; Noh, Joseph J; Shim, Jung In; Lee, Yoo-Young; Kim, Tae-Joong; Lee, Jeong-Won; Kim, Byoung-Gie; Bae, Duk-Soo; Park, Won; Choi, Chel Hun
宫颈癌
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer

二次细胞减灭术与辅助化疗之间的间隔时间与复发性卵巢癌患者的生存率无关。

期刊:Journal of Ovarian Research
影响因子:4.2
doi:10.1186/s13048-019-0602-5
Jeong, Soo Young; Choi, Chel Hun; Kim, Tae Joong; Lee, Jeong Won; Kim, Byoung-Gie; Bae, Duk Soo; Lee, Yoo-Young
细胞生物学
肿瘤
肿瘤免疫
卵巢癌
发表日期：2019
文献求助 收藏

Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer.

Wee1激酶抑制剂联合放射疗法对人宫颈癌的抗肿瘤作用

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-019-51959-3
Lee Yoo-Young, Cho Young-Jae, Shin Sung-Won, Choi Changhoon, Ryu Ji-Yoon, Jeon Hye-Kyung, Choi Jung-Joo, Hwang Jae Ryoung, Choi Chel Hun, Kim Tae-Joong, Kim Byoung- Gie, Bae Duk-Soo, Park Won, Lee Jeong-Won
肿瘤
Human
发表日期：2019
文献求助 收藏